Facebook Pixel

Ratings for Dr. Mehmet Fevzi Ozkaynak

1
Staff
1
Punctuality
1
Helpfulness
1
Knowledge

Ask a lot of questions and make sure you do your homework

Was this rating useful? 0

flag | Submitted February 2, 2011

5
Staff
5
Punctuality
5
Helpfulness
5
Knowledge

A rare doctor who takes time to listen and give a complete exam, finds unusual problems isn't afraid to consult with other doctors. Cares about his patients!

Was this rating useful? 0

flag | Submitted April 2, 2010

Rate this Doctor

Dr. Mehmet Fevzi Ozkaynak's Credentials



Accepting New Patients

Yes, this doctor is accepting new patients


Biography

Professor of Pediatrics Pediatric Hematology/Oncology, New York Medical College Director, Pediatric Blood and Marrow Transplant Program Maria Fareri Children’s Hospital at Westchester Medical Center EDUCATION: University of Hacettepe, School of Medicine, Ankara (1978) POSTGRADUATE EDUCATION AND TRAINING: Residency in Pediatrics, Hacettepe Children’s Hospital, Ankara (1978-1982) Residency in Pediatrics, Childrens Hospital of Los Angeles (1989-1991) Fellowship in Peds. Hem/Onc/BMT, Childrens Hospital of LA (1986-1989) ACADEMIC APPOINTMENTS: 2009-2010: Interim Chief, Peds Hem/Onc, NYMC, Dept. of Pediatrics 2003-Present: Professor of Pediatrics, New York Medical College 1999-2003: Associate Professor of Pediatrics, New York Medical College 1994-1999: Assistant Professor of Pediatrics, New York Medical College 1992-1994: Asst. Professor of Pediatrics, University of Southern California 1994-Present: Director, Peds. Blood & Bone Marrow Transplantation, Maria Fareri Children’s Hospital at Westchester Medical Center 1990-1993: Assistant Clinical Director, Autologous Bone Marrow Transplantation Program, Division of Hematology/Oncology, Childrens Hospital of Los Angeles 1993-1994: Director, Peripheral Stem Cell Program, Childrens Hospital of Los Angeles SELECTED ACTIVITIES: 1994-1999: Chairperson, Childrens Cancer Group Protocol #0935: A Phase I Study of Chimeric Human/Murine AntiGD2 Monoclonal Antibody (ch14.18) with GM-CSF in Children with Neuroblastoma. 1998-Present: Vice-Chairperson, Childrens Oncology Group #ANBL0032: Phase III Randomized Study of Chimeric Anti-GD2 in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue. 1997-2005: Chairperson, Childrens Oncology Group Protocol # AS973: A Randomized Comparison Between Antibiotics Alone and Antibiotics Plus G-CSF in Pediatric Patients with Chemotherapy Induced Febrile Neutropenia. 2000-2007: Chairperson, Pediatric Blood and Marrow Consortium, A Phase I Trial of Amifostine with L-PAM, Carboplatin, Etoposide with Escalating Doses of Cyclophosphamide with Autologous PBSC in Children with Pediatric Solid Tumors 2009-Present: Chairperson, Childrens Oncology Group #ANBL0931: A Comprehensive Safety Trial of Chimeric Antibody 14.18 (Ch14.18) with GM-CSF, IL-2 AND Isotretinoin in Hgh-Risk Neuroblastoma Patients Following Myeloablative Therapy. HOSPITAL AFFILIATIONS Childrens Hospital LA, LA, CA, Attending, 7/1991 – 6/1994 Maria Fareri Childrens Hospital/Westchester Medical Center, Valhalla, NY, Attending, 7/1994-Present Vassar Medical Center, Poughkeepsie, NY : Consultant, 2/1996-Present Danbury Hospital, Danbury, CT: Consultant, 7/1997-Present Our Lady of Mercy/Montefiore North, Bronx, NY: Consultant, 1/1999-Present


Languages

  • English

Education

  • Hacettepe Univ, Tip Fak, Hacettepe, Ankara, Turkey (Grad. 1978)

Other Specialties


Areas of Expertise

  • Blood and bone marrow donation
  • Bone marrow biopsy and aspiration

Awards & Recognitions

Unavailable


Publications & Research

Unavailable


Insurance accepted by this Doctor

Other patients have successfully used these insurance providers, please call the Doctor's office to find out if your insurance plan is accepted.
Aetna
Blue Cross / Blue Shield
CIGNA
Medicare


Sign up for our newsletter to get the latest health news and tips.